Kingsley Stuart A 4

What Happened
Kingsley Stuart A, a director of Indivior Pharmaceuticals (INDV), received a grant of 3,722 Restricted Stock Units (RSUs) on 2026-01-26. The grant is reported at $0.00 per unit (no cash paid at grant). Each RSU is a contingent right to receive one share of common stock if and when the RSUs vest.

Key Details

• Transaction date: 2026-01-26; SEC filing date: 2026-01-28 (appears timely under the Form 4 two-business-day rule).
• Transaction type/code: Award/Grant (A).
• Amount: 3,722 RSUs; reported price $0.00; reported value at grant $0.
• Shares owned after transaction: not specified in the provided filing data.
• Footnote: RSUs vest on the day immediately preceding the date of the first annual meeting of stockholders following the grant date, subject to the reporting person's continued service (per footnote F1).

Context
RSUs are compensation awards that convert to shares only at vesting and therefore are not an open-market purchase or sale. Grants like this typically reflect board compensation rather than an immediate market signal; taxable events generally occur when RSUs vest and shares are delivered.